Global Synthetic Biology Market Expected to Reach USD 66.7 Billion by 2033 - IMARC Group

Global Synthetic Biology Market Statistics, Outlook and Regional Analysis 2025-2033

The global synthetic biology market size was valued at USD 18.5 Billion in 2024, and it is expected to reach USD 66.7 Billion by 2033, exhibiting a growth rate (CAGR) of 15.3% from 2025 to 2033.

The synthetic biology market is driven by the growing demand for sustainable solutions across industries, particularly in manufacturing, agriculture, and energy production. The increasing need for bio-based alternatives is accelerating the adoption of innovative technologies in the field. For example, on November 5, 2024, BASF and Acies Bio announced their collaboration to scale the OneCarbonBio synthetic biology platform. This platform converts renewable methanol, derived from captured CO2 emissions, into bio-based fatty alcohols for sustainable surfactant and specialty chemical production. By combining microbial strain advancements with BASF’s global expertise, the initiative supports net-zero manufacturing and resilient supply chains. Ongoing innovations in microbial engineering and metabolic pathway design are facilitating the production of renewable biofuels, biodegradable materials, and high-efficiency agricultural solutions, reducing reliance on non-renewable resources. Advancements in enzyme engineering and synthetic pathways further enhance process efficiency and environmental sustainability, strengthening the market’s growth trends.

The increasing application of synthetic biology in environmental solutions is also a major driver for this market, supporting initiatives in bioremediation, pollution management, and carbon capture to achieve global conservation goals. Synthesis of synthetic organisms tailored to meet ecological challenges is accelerating quickly with progress in artificial intelligence and computational design. On November 6, 2024, Asymchem launched its STAR platform, showing how AI and synthetic biology could completely transform protein engineering. With the potential of machine learning and active learning, STAR now brings timelines for protein evolution down from months to weeks. Glucose dehydrogenase is a significant success in terms of increase in activity and stability of the enzymes with simpler research processes. These innovations show the contribution of synthetic biology to addressing environmental challenges and providing breakthroughs across sectors in reinforcing its importance as a transformational technology in sustainability-focused industries and beyond.

Global Synthetic Biology Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share on account of its advanced infrastructure, high consumer spending, technological advancements, robust industry presence, and strong focus on innovation and sustainability.

North America Synthetic Biology Market Trends:

The synthetic biology market in North America is growing rapidly, driven by advancements in genetic engineering and substantial investments in research and development (R&D). According to a February 2024 report by Australia’s national science agency, CSIRO, and Main Sequence Ventures, synthetic biology could underpin an industry worth up to USD 30 Billion per year and by 2040, create more than 50,000 new jobs. Agriculture and food applications account for over 45% of Australian-founded synthetic biology start-ups, raising USD 290 Million in capital investments. Additionally, USD 44.5 Million in research grants has been distributed in the last three years. The region benefits from robust biotechnology firms, academic institutions, and government initiatives, supporting innovations in healthcare, agriculture, and environmental solutions, with personalized medicine and biomanufacturing driving further growth.

Europe Synthetic Biology Market Trends:

Europe's synthetic biology market is growing steadily as the focus on sustainability and green technologies takes center stage. The leader countries in adopting synthetic biology for renewable energy, industrial biotechnology, and pharmaceuticals are Germany, the United Kingdom, and France. Regulatory frameworks and funding from the European Union support the innovation and encourage collaboration for advancements in the field.

Asia-Pacific Synthetic Biology Market Trends:

Asia Pacific is one of the most promising markets for the synthetic biology market, given the increasing investments in biotechnology and its growing demand in agricultural and industrial applications. China, India, and Japan are the driving countries in the adoption of synthetic biology to improve crop yield, develop bio-based products, and solve healthcare challenges. Supportive government policies and expanding research infrastructure further accelerate market development in this region.

Latin America Synthetic Biology Market Trends:

The Latin American synthetic biology market is changing, especially with increased interest in the production of agricultural biotechnology and biofuels. Brazil and Argentina are looking to use synthetic biology to drive sustainable farming practices and avoid fossil fuel dependency. In its early stages, awareness and collaboration with global players open up new opportunities for growth.

Middle East and Africa Synthetic Biology Market Trends:

In the Middle East and Africa, the synthetic biology market is slowly picking up steam due to the emphasis on water and energy sustainability. Governments in the region are exploring synthetic biology solutions for biofuel production and waste management as part of the environmental solution. The market is constrained by limited infrastructure and awareness, but strategic investments and partnerships are beginning to take shape.

Top Companies Leading in the Synthetic Biology Industry

Some of the leading synthetic biology market companies include Agilent Technologies Inc., Amyris Inc., Codexis Inc., Danaher Corporation, Eurofins Scientific, GenScript Biotech Corporation, Illumina Inc., Merck KGaA, New England Biolabs, Synthego Corporation, Thermo Fisher Scientific Inc., Twist Bioscience, and Viridos Inc, among many others. On August 9, 2024, Agilent Technologies and Sangon Biotech partnered to enhance capabilities in synthetic biology and multi-omics, focusing on nucleic acid synthesis and sequencing. Leveraging Agilent's advanced technologies and Sangon’s expertise, the collaboration aims to drive innovation in biotechnology, supporting China’s ‘14th Five-Year Plan.’ The partnership includes launching a ‘Digital Demonstration Laboratory’ to optimize lab efficiency, reduce energy consumption, and accelerate technological breakthroughs. Agilent’s solutions will strengthen Sangon’s competitiveness, advancing synthetic biology and nucleic acid-related applications across biomedical and diagnostics industries in China.

Global Synthetic Biology Market Segmentation Coverage

• Based on the product, the market is classified into oligonucleotide/oligo pools and synthetic DNA, enzymes, cloning technologies kits, xeno-nucleic acids, and chassis organism. The oligonucleotide/oligo pools and synthetic DNA leads the market segment since they play an important role in a variety of applications, including gene editing, diagnostics, and therapeutic development. Growing demand for CRISPR technology, synthetic biology, and precision medicine pushes them to grow. These tools render cost-effective, high-throughput synthesis, which fulfills the increasing demand for scalable solutions in research and industrial biotechnology. Their flexibility and versatility render them inalienable in the creation of advanced diagnostics and targeted therapies, winning a big share of the market.
• On the basis of technology, the market has been categorized into NGS technology, PCR technology, genome editing technology, bioprocessing technology, and others. The PCR technology segment leads the market, due to its pivotal role in amplifying and analyzing nucleic acids. The widespread application of PCR in detecting infectious diseases, genetic disorders, and cancer biomarkers drives its dominance. Innovations such as real-time PCR and digital PCR further enhance its precision and efficiency, increasing adoption. The technology's reliability, accessibility, and scalability cement its position as the largest segment in synthetic biology and genomics.
• Based on application, the market is bifurcated into healthcare (clinical and non-clinical/research), and non-healthcare (biotech crops, specialty chemicals, biofuels, and others), amongst which healthcare dominates the market as it is extensively in the development of drugs, diagnostics, and personalized medicine. Synthetic biology provides new avenues for innovative vaccine, gene therapy, and diagnostic tool design, helping to meet complex health challenges. Increasing attention to precision medicine and genomic advancements drive demand in the healthcare sector. Other efforts to reform health systems and address chronic conditions further emphasize the size of the market and growth prospects for this segment.

Browse IMARC Related Reports on Synthetic Biology Market:

• United States Synthetic Biology Market Report
   
• India Synthetic Biology Market Report